Friday, February 13, 2015

Top Promising Stocks To Watch Right Now

Walt Disney (NYSE: DIS  ) will release its quarterly report on Wednesday, and investors still have high expectations that the multimedia empire can sustain its impressive growth rates well into the future. With its smart acquisitions of content-production powerhouses Lucasfilm, Marvel, and Pixar and with an ironclad grip over the sports-programming world with its leading ESPN network, Disney has held competitors at bay and has become a must-have source of content both for cable providers and for streaming-video giants Netflix (NASDAQ: NFLX  ) and Amazon.com (NASDAQ: AMZN  ) , and shareholders expect earnings growth to continue well into the future.

When it comes to vertical integration in entertainment, Disney has mastered the industry. With so many cross-promotional opportunities, Disney builds its customer base from the earliest of ages and holds onto them throughout their lives. Yet the stock rose at more than double the pace of the Dow Jones Industrials last year, raising questions about whether even such a promising company might be overvalued. Let's take an early look at what's been happening with Walt Disney over the past quarter and what we're likely to see in its report.

Top Promising Stocks To Watch Right Now: Thermo Fisher Scientific Inc(TMO)

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Its Analytical Technologies segment offers analytical instruments to analyze prepared samples, software interpretation tools, laboratory information management systems, and laboratory automation systems; environmental instruments and integrated systems for environmental monitoring, safety, and security applications; and process instruments, integrated systems, and measurement solutions. It also provides diagnostics products used in healthcare laboratories to prepare and analyze patient samples; and biosciences products comprising reagents and consumables used in life science research, drug discovery, and biopharmaceutical production. The company?s Laboratory Products and Services segment offers laboratory equipment, including sample preparation, environment storage and handling equipment, and laboratory workstations; laboratory consumables; research market solutions consisting of chemicals, instruments and apparatus, liquid handling pumps and devices, and capital equipment and consumables; and healthcare market products comprising analytical equipment, diagnostic tools, and reagents and consumables. It also provides workplace and first responder equipment, protective gear, and apparel; and packaging, warehousing, distribution, labeling, pharmaceutical and biospecimen storage, and analytical laboratory services in the area of drug discovery and pharmaceutical clinical trials. The company serves pharmaceutical and biotechnology companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental and industrial process control settings primarily in the United States, Germany, and the United Kingdom. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Top Headline
    General Electric Co (NYSE: GE) announced its plans to acquire some assets from Thermo Fisher (NYSE: TMO) for around $1.06 billion.

  • [By Victor Selva]

    As we can see, the firm has a lower ROE than Abbott Laboratories (ABT), Thermo Fisher Scientific Inc. (TMO) and CVS Caremark Corporation (CVS).

    Final Comment

  • [By Tess Stynes]

    General Electric Co.'s(GE) healthcare unit agreed to acquire several of Thermo Fisher Scientific Inc.'s(TMO) life-sciences businesses for roughly $1.06 billion.

Top Promising Stocks To Watch Right Now: Nissan Motor Co Ltd (NSANF)

NISSAN MOTOR CO., LTD. is an automobile manufacturer. The Company has two business segments. The Automobile segment is engaged in the manufacturing, trading and distribution of various types of automobiles, marine products and accessories, as well as the research, development and sale of lithium-ion secondary batteries. The Sales Financing segment is engaged in the provision of sales financing, as well as property and casualty insurance services, among others. On November 11, 2013, the Company announced that it had established an Indonesia-based subsidiary, which is engaged in the captive finance business to make loans to the customers of Indonesia. Advisors' Opinion:
  • [By Peter Valdes-Dapena]

    Six of the cars earned the Institute's lowest rating of "Poor." Those were the Nissan (NSANF) Versa, Toyota (TM) Prius c, Hyundai Accent, the Mitsubishi Mirage, Chrysler Group's Fiat 500 and the Honda (HMC) Fit. The Mazda2, Kia Rio, Toyota Yaris and Ford (F, Fortune 500) Fiesta were deemed Marginal, the second-worst of four possible ratings. Most of these cars have done well in the Institute's other crash tests and in government tests. The Insurance Institute is a private organization financed by auto insurers.

  • [By Blake Ellis]

    Industries boasting the highest percentage of companies with perfect scores include law, banking and financial services, and retail and consumer products. Companies new to the 100% club include Nissan (NSANF), General Electric (GE, Fortune 500) and Procter & Gamble (PG, Fortune 500). Other companies among the most improved this year (though they haven't achieved perfect scores yet) include Wal-Mart (WMT, Fortune 500), which saw its score jump from a 60 to 80 after it introduced same-sex benefits for employees, and Cracker Barrel (CBRL), which rose 10 points to a score of 45 after it launched a LGBT employee network and implemented a non-discrimination policy for LGBT employees.

  • [By Peter Valdes-Dapena]

    Nissan (NSANF) will ask owners of effected vehicles to bring their vehicles to a Nissan or Infiniti dealer to have the ABS computer chips reprogrammed. The service will be performed at no charge. No accidents or injuries have been reported due to the problem, Nissan said.

Top 10 Small Cap Companies To Own For 2015: NewMarket Corp (NEU)

NewMarket Corporation (NewMarket), incorporated in 2004, is a holding company, which is the parent company of Afton Chemical Corporation (Afton), Ethyl Corporation (Ethyl), NewMarket Services Corporation (NewMarket Services), and NewMarket Development Corporation (NewMarket Development). Each of the Company�� subsidiaries manages its own assets and liabilities. Afton encompasses the petroleum additives business, while Ethyl represents the sale and distribution of tetraethyl lead (TEL) in North America and certain petroleum additives manufacturing operations. NewMarket Development manages the property, which it owns in Richmond, Virginia. NewMarket Services provides administrative services to NewMarket, Afton, Ethyl, and NewMarket Development. NewMarket Services departmental expenses and other expenses are billed to NewMarket and each subsidiary pursuant to services agreements between the companies.

As a specialty chemicals company, Afton develops, manufactures, and blends formulated fuel and lubricant additive packages, and markets and sells these products globally. Afton is a lubricant and fuel additives companies globally. Lubricant and fuel additives are products for maintenance and reliable operation of all vehicles and machinery. Ethyl provides contract manufacturing services to Afton and to third parties and is one of the marketers of TEL in North America. NewMarket Development manages the property, which it owns on a site in Richmond, Virginia consisting of approximately 64 acres.

Petroleum Additives

Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It manufactures chemical components, which are selected to perform specific functions and combine those chemicals with other components to form additive packages for use in specified end-user applications. The petroleum additives market is an international marketplace, with customers ranging from oil companies and refineries t! o original equipment manufacturers (OEMs) and other specialty chemical companies. Lubricant additives are ingredients for lubricating oils. Lubricant additives are used in a range of vehicle and industrial applications, including engine oils, transmission fluids, gear oils, hydraulic oils, turbine oils, and in other application where metal-to-metal moving parts are utilized. Lubricant additives are organic and synthetic chemical components, which enhance wear protection, prevent deposits, and protect against the hostile operating environment of an engine, transmission, axle, hydraulic pump, or industrial machine.

Lubricants are used in every piece of operating machinery from heavy industrial equipment to vehicles. Lubricants provide a layer of protection between moving mechanical parts. Lubricants serve the functions, such as friction reduction, heat removal and containment of contaminants.

The Company offers a range of lubricant additive products, each of which is composed of component chemicals specially selected to perform desired functions. It manufactures the chemical components and blends these components to create formulated additives packages. Purchasers of lubricant additives tend to be oil companies, distributors, refineries, and compounders/blenders. The engine oils market�� primary customers include consumers, service dealers, and OEMs. Afton offers products, which enhances the performance of mineral, part-synthetic, and fully-synthetic engine oils.

The driveline additives submarket is consisted of additives designed for products, such as transmission fluids, gear oils, and off-road fluids. Transmission fluids serve as the power transmission and heat transfer medium in the area of the transmission. Gear oil additives lubricate gears, bearings, clutches, and bands in the gear-box and are used in vehicles, off-highway, hydraulic, and marine equipment. Other products in this area include hydraulic transmission fluids, universal tractor fluids, power ste! ering flu! ids, shock absorber fluids, gear oils and lubricants for machinery. These additives are sold to oil companies and often sold to vehicle OEMs for new vehicles. End-products are also sold to service dealers for aftermarket servicing (service-fill), as well as retailers and distributors.

The industrial additives submarket is consisted of additives designed for products for industrial applications, such as hydraulic fluids, grease, industrial gear fluids, industrial specialty applications, and metalworking additives. This submarket also shares in the 30% of the market not covered by engine oils. These products must conform to industry specifications, OEM requirements and/or application and operating environment demands. Industrial additives are sold to oil companies, service dealers for after-market servicing, and distributors.

The types of fuel additives the Company offers include gasoline performance additives, which clean and maintain fuel delivery systems, including fuel injectors and intake valves, in gasoline engine; diesel fuel performance additives, which perform similar cleaning functions in diesel engines; cetane improvers, which increase the cetane number in diesel fuel by reducing the delay between injection and ignition; stabilizers, which reduce or eliminate oxidation in fuel; corrosion inhibitors, which minimize the corrosive effects of combustion by-products and prevent rust; lubricity additives, which restore lubricating properties lost in the refining process; cold flow improvers, which improve the pumping and flow of diesel in cold temperatures, and octane enhancers. It offers a range of fuel additives globally and sells its products to fuel marketers and refiners, as well as independent terminals and other fuel blenders.

Real Estate Development

The real estate development segment represents the operations of Foundry Park I, LLC (Foundry Park I). The Company is exploring various development opportunities for other portions of the proper! ty it own! s, as the demand warrants.

All Other

The All other category includes the continuing operations of the TEL business (primarily sales of TEL in North America), as well as contract manufacturing performed by Ethyl. Ethyl manufacturing facilities include its Houston, Texas and Sarnia, Ontario, Canada plants. The Houston plant is engaged in petroleum additives manufacturing and produces both lubricant additives and fuel additives. The Sarnia plant is engaged in petroleum additives manufacturing and produces fuel additives. The All other category financial results include a service fee charged by Ethyl for its production services to Afton. Its remaining manufacturing facilities are part of Afton and produce both lubricant additives and fuel additives.

The Company competes with Berkshire Hathaway Inc., ExxonMobil Chemical, Royal Dutch Shell plc, Chevron Oronite Company LLC, BASF AG, Chevron Oronite Company LLC, The Lubrizol Corporation, Innospec, Inc., Eurenco and EPC - U.K.

Advisors' Opinion:
  • [By John Udovich]

    The biotech sector has been pretty exciting this year�with small cap biotech stocks Prana Biotechnology Limited (NASDAQ: PRAN) and TNI BioTech (OTCMKTS: TNIB) having recently produced noteworthy news for investors�while Acceleron Pharma, Inc (NASDAQ: XLRN), Ophthotech (NASDAQ: OPHT) and BIND Therapeutics (NASDAQ: BIND) have just�set term sheets for their upcoming IPOs. Just consider all of the following recent news:

    Surge in Biotech IPOs. Unquote.com has noted�a surge in biotech IPOs this year as there have been�almost 30 biotech IPOs since January - marking a 13-year high and sparking some concerns about a bubble. More specifically and according to the National Venture Capital Association (NVCA), there was just one venture capital-backed biotech IPO in the US in the first quarter of this year, but this was followed by a massive increase of 20 in�the second quarter and a�further six since July. There has also been a small uptick in�venture capital-backed European biotech companies going public (four) with�a listing on the Nasdaq appearing to be the most popular or rather the safest option. � New IPO Term Sheets. This month, a couple of small cap biotech companies announced their terms for upcoming IPOs, including 1)�Acceleron Pharma, Inc, a clinical stage biotech developing protein therapeutics for cancer and rare diseases, plans to raise $65 million by offering 4.7 million shares at a price range of $13 to $15; 2) Ophthotech, a clinical-stage biotech developing therapeutics for eye diseases, plans to raise $100 million by offering 5.7 million shares at a price range of $16 to $19; and 3) BIND Therapeutics, a clinical-stage biotech developing a platform of targeted and programmable therapeutics, plans to raise $71 million by offering 4.7 million shares at a price range of $14 to $16. Biotechs Invest More on R&D. The 2013 BDO Biotech Briefing examined the most recent 10-K SEC filings of publicly traded companies listed on the Nasdaq Biotechnolog

Top Promising Stocks To Watch Right Now: Lenovo Group Ltd (LNVGY)

Lenovo Group Limited (Lenovo) is a personal technology company serving customers in more than 160 countries. The Company is a personal computer (PC) vendor. The Company develops, manufactures and markets technology products and services. Its product lines include Think-branded commercial PCs and Idea branded consumer PCs, as well as servers, workstations, and a family of mobile Internet devices, including tablets and smart phones. Lenovo operates seven research and development centers and more than 46 world-class labs, including research centers in Yamato, Japan; Beijing, Shanghai and Shenzhen, China; and Raleigh, North Carolina, the United States. The Company is also engaged in investment holding. It operates in three segments: China, emerging markets (excluding China) and mature markets. Lenovo offers a range of commercial desktops to businesses of all sizes.

The Company�� products include laptops, tablets, desktops, workstations and servers. In May 2010, it launched the LePhone smartphone in China. During the fiscal year ended March 31, 2011 (fiscal 2011), China accounted for 46.4% of the Company�� total sales. During fiscal 2011, Emerging Markets (excluding China) accounted for 17.9% of the Company�� total sales. During fiscal 2011, Mature Markets accounted for 35.7% of the Company�� total sales. Its brands include ThinkPad notebook, as well as products carrying the ThinkCentre, ThinkStation, ThinkServer, IdeaCentre and IdeaPad sub-brands.

Advisors' Opinion:
  • [By Timothy Green]

    PCs are much lower margin, but they still contributed about $1 billion in operating profit in 2013. HP is the second-largest PC vendor in the world, and the more focused HP will be better-suited to compete with Lenovo Group (NASDAQOTH: LNVGY  ) in the PC market without being tied to the enterprise business.

  • [By vinaysingh]

    Apart from the above-mentioned business areas, HP's core competency still lies in PC markets and we are already aware of the smart devices wave that has almost swept the demand for desktops. In spite of battered demand in consumer PC market, HP increased the unit shipments by 6% y-o-y due to improved demand conditions in the commercial PC markets. As a result of a sturdy performance, HP's market share is now just slightly lower than that of Lenovo (LNVGY), the leader in the PC market. A report from Gartner showcases the shares of enterprises that occupy this market.

  • [By Mihir Mehta, Mehta]

    It is prudent for investors to watch out for the development of Apple's share in China, especially after Google announced the sale of Motorola's mobility division to Lenovo (NASDAQOTH: LNVGY  ) . This deal can prove to be a major threat to Apple in the Chinese markets, as Lenovo has a better position there . Thus, the onus will be on Apple to maintain its innovation streak and develop a robust way to capture the Asian markets amid competition from low-priced devices from Lenovo and Samsung.

  • [By WWW.DAILYFINANCE.COM]

    Personal systems is HP's largest division in terms of sales.

    This was due in no small part to sales of desktop PCs and notebooks, which both grew by 6 percent. Personal systems, by the way, is HP's largest division in terms of sales. Intel, which in spite of its efforts at diversification is still strongly tied to the PC market, showed an 8 percent year-over-year gain in top line (to $13.8 billion) in its most recent quarter. Much of this increase came from the firm's core PC client group, which was responsible for nearly 60 percent of that total. Here at home, HP's 7 percent bump was eclipsed by the recently taken private Dell's approximately 13 percent growth. Then there's the global market leader, China's Lenovo (LNVGY), which enjoyed a fat rise of roughly 15 percent. Even Apple Experienced a Growth Bump Even one of the most prominent players in mobile hardware is cashing in its chips on PCs. Apple's portable gadgets might get the visibility and the buzz, but in the firm's most recent quarter, it was computers that won the growth contest. The company's Mac line saw an 18 percent annual rise in terms of units sold and a 13 percent increase in terms of net sales. Both figures trumped the growth in iPhones, iPads and iPods. In fact, when looking at Apple's four main product lines, the Mac was one of only two (along with the iPhone) to record an increase in unit sales across the most recent three- and nine-month periods. Macs are helping Apple pump out the profits ($7.7 billion in net income for the most recent quarter, on $37.4 billion in sales). They're also providing they're share of cash to fund the company's dividend, an unusual feature for a tech company stock. Like a Phoenix The gains in the PC market are healthy and encouraging -- and if current trends continue, they're also likely sustainable. All that's to say that things are looking pretty good for a technology that was written off by the skeptics not so long ago. More from Eric Vol

Top Promising Stocks To Watch Right Now: Otoc Ltd (OTC)

OTOC Limited through its wholly owned subsidiaries OTOC Group Pty Ltd and Whelans (WA) Pty Ltd (Whelans) provides construction and turnkey camp/ village installations, environmental, surveying, mapping, town planning, engineering, project delivery and specialist consulting services across the infrastructure, resources and energy sectors. The Company operates in two segments: OTOC Operations and Whelans Consulting Operations. OTOC Operations (OTOC) provides camp/village installations to the Western Australian resources and infrastructure sector. Whelans Consulting Operations (Whelans) provides surveying, mapping and town planning services throughout Western Australian. In July 2013, the Company announced that its wholly owned subsidiary OTOC Australia has expanded its Facilities Division through the acquisition of full ownership of a 700 person commercial kitchen/diner facility. Advisors' Opinion:
  • [By Cesc]

    ��pproximately two-thirds of external Software segment revenue is annuity based, coming from recurring license charges and ongoing post-contract support. The remaining one-third relates to one-time charge (OTC) arrangements in which clients pay one, up-front payment for a perpetual license.��/p>

  • [By Jim Powell]

    Alas, there is a catch with Samsung. At the present time, the company is only available in the US through the Over The Counter (OTC) market, known as the Pink Sheets.

  • [By Holly LaFon]

    Perrigo (PRGO) is a global manufacturer of over-the-counter (OTC) store brand and generic prescription pharmaceuticals, infant formulas, nutritional products and active pharma ingredients. The company is the dominant player in the OTC drug market with the largest distribution network and broadest range of product offerings. The OTC store brands have increased their market share by about 1-2% annually at the expense of national name product given their superior value proposition to both the consumer and retailers. Perrigo has numerous growth drivers over the next few years including the continued penetration of OTC store brands and introduction of new product categories. The stock sells at a reasonable valuation, in our opinion, given the company's strong management team, financial returns and long-term growth prospects.

Top Promising Stocks To Watch Right Now: China Yuchai International Limited (CYD)

China Yuchai International Limited, through its subsidiaries, manufactures and sells diesel and natural gas engines primarily in the People�s Republic of China (PRC). It operates in two segments, Yuchai and HLGE. The company provides engines for light, medium, and heavy-duty for highway vehicles; generator sets; and marine and industrial applications, as well as supplies after-market parts and services. It also offers diesel power generators that are used in the construction and mining industries; diesel engine parts; and remanufacturing services. In addition, the company operates hotels and engages in property development activities primarily in the PRC and Malaysia. It distributes its products directly to auto plants and agents. The company was founded in 1951 and is based in Singapore.

Advisors' Opinion:
  • [By Rich Duprey]

    Following the abrupt resignation of director and President Benny H. Goh on May 27, China Yuchai International (NYSE: CYD  ) has been operating with an interim officer, Kok Ho Leong,�who also held the position of CFO while a replacement was found.

Top Promising Stocks To Watch Right Now: Keryx Biopharmaceuticals Inc.(KERX)

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment cancer and renal disease. The company?s products under development include KRX-0401 (perifosine), an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, as well as affects other pathways associated with programmed cell death, cell growth, cell differentiation, and cell survival. Its KRX-0401 is in Phase III clinical development stage for the treatment of refractory advanced colorectal cancer and multiple myeloma, as well as in Phase I and Phase II clinical development stages for the treatment of other tumor types. The company is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that is in Phase III clinical development for the treatment of hyperphosphatemia in patients with end-stage renal disease o n dialysis. Keryx Biopharmaceuticals, Inc. has commercial license agreements with Zentaris AG for the development of KRX-0401; Panion & BF Biotech, Inc. for the development and marketing of Zerenex; and Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Zerenex in Japan. The company was founded in 1997 and is based in New York, New York.

Advisors' Opinion:
  • [By Keith Speights]

    For example, Keryx Biopharmaceuticals (NASDAQ: KERX  ) reported no revenue for 2012. Not a dime. The company lost $22.7 million last year and even more the year before that. However, those financial results really aren't important at this point.

  • [By Bryan Murphy]

    Just so there's no misunderstanding, Keryx Biopharmaceuticals (NASDAQ:KERX) hasn't run into any unexpected trouble with one of its drugs. There's no FDA impasse on the horizon that should be pushing KERX lower. This isn't even a judgment call on the company or its potential with flagship kidney disease drug Auryxia. This is just a reality check for the stock, which as is often the case with biotech stocks,� has taken on a predictable life of its own. Problem: The predictive clues just turned dire.

Top Promising Stocks To Watch Right Now: Deutsche Boerse AG (DB1)

Deutsche Boerse AG is a Germany-based international financial marketplace operator. It operates four business segments: Xetra; Eurex; Clearstream, and Market Data & Analytics. The Xetra business segment comprises three business areas: cash market using the Xetra electronic trading system and Xetra Frankfurt specialist trading; central counterparty for equities, and admission of securities to listing. The Eurex business segment comprises four business areas: electronic derivatives market trading platform Eurex; electronic options trading platform ISE; over-the-counter trading platforms Eurex Bonds, Eurex Repo, and Eurex Clearing. The Clearstream business segment comprises three business areas: custody, administration and settlement services for securities; global securities financing services, and investment funds services. The Market Data & Analytics business segment comprises two business areas: sales of price information and information distribution, and index development and sales. Advisors' Opinion:
  • [By Nikolaj Gammeltoft]

    The mishap followed others earlier in the week. An Oct. 30 malfunction interrupted data transmission at Deutsche Boerse AG (DB1)�� International Securities Exchange, while Nasdaq was unable to distribute prices for its benchmark stock indexes for almost an hour on Oct. 29. The breakdowns refocused concern that the distribution of trading over dozens of mostly automated venues has made U.S. securities markets fundamentally flawed.

Top Promising Stocks To Watch Right Now: Cannabis Science Inc (CBIS)

Cannabis Science, Inc., incorporated on May 4, 2007, is a development-stage company. The Company is engaged in the creation of cannabis-based medicines, both with and without psychoactive properties, to treats disease and the symptoms of disease, as well as for general health maintenance. On February 9, 2012, the Company acquired GGECO University, Inc. (GGECO). On March 21, 2012, the Company acquired Cannabis Consulting Inc. (CCI Group).

The Company is engaged in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.

Advisors' Opinion:
  • [By Bryan Murphy]

    The last few days have been nothing less than incredible for stocks like Cannabis Science Inc. (OTCMKTS:CBIS), Medbox Inc. (OTCMKTS:MDBX), Growlife Inc. (OTCBB:PHOT), and Medical Marijuana Inc. (OTCMKTS:MJNA). MJNA shares have jumped 90% since last Friday. PHOT is up 51% for the same timeframe. CBIS has grown 150%, while MDBX is up 112%. The reason? It's largely the legalization of recreational marijuana in Colorado - a law that went into effect as of January 1st. The legalization of medical marijuana in Illinois on the same day didn't hurt either. And truth be told, the event-based rally from the likes of Medbox and Cannabis Science makes basic sense - it's a landmark shift in the way this country views and treats marijuana. On the flipside, before wading any deeper into stocks like Medical Marijuana or Growlife, current and would-be owners might want to take a step back and look at the bigger picture.

  • [By John Udovich]

    Although its summer, there has been a steady stream of good news about medical marijuana even though important small cap marijuana stocks�Medical Marijuana Inc (OTCMKTS: MJNA) and Cannabis Science Inc (OTCMKTS: CBIS) have been fairly quietly lately while Growlife Inc (OTCBB: PHOT), a more indirect play on the spread of legalized marijuana, has produced�some news for investors:

  • [By John Udovich]

    Small cap marijuana stocks Medical Marijuana Inc (OTCMKTS: MJNA), Cannabis Science Inc (OTCMKTS: CBIS), Medbox Inc (OTCMKTS: MDBX), Growlife Inc (OTCBB: PHOT) and HEMP, Inc (OTCMKTS: HEMP) were all surging by double digits yesterday thanks in part to legal sales of pot beginning in Colorado.

No comments:

Post a Comment